What is Power Injection Infusion Market?
Power injection infusion is used for injecting contrast media into the bloodstream that additionally allows visualization for diagnosing using x-ray, computed tomography, resonance, and different medical imaging modality. Power injection infusion facilitates consistent flow rate and volume of targeted distinction media within the targeted space throughout medical imaging. This enables better image and maximum improvement during a little period of your time. Per the Centres for disease control and prevention (CDC), in 2018 there have been calculable 795,000 suffered from the stroke within the U.S.
The market study is being classified by Type (Single Lumen Catheter Systems and Double Lumen Catheter Systems) and major geographies with country level break-up.
Becton Dickinson and Company (United States), Smiths Medical Inc. (United States), B. Braun Medical Inc. (United States), Bayer Healthcare (Germany), TekMed Pty Ltd. (Australia), Covidien (Ireland), AngioDynamics (United States), Bracco S.p.A (Italy), Medtron AG (United States), Nemoto Kyorindo Co. Ltd. (Japan) and Ulrich GmBH (Germany) are some of the key players profiled in the study.
With the increased research and development in the field of power injection infusion, there are countries ruling the market and will be ruling in the coming decade. The high rate of prevalence of cardiovascular disease and cancer increases the demand for the power injection infusion market. The increasing number of domestic players is increasing the competition in the market. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Power Injection Infusion market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Power Injection Infusion market by Type, Application and Region.
On the basis of geography, the market of Power Injection Infusion has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Prevalence of Cardiovascular Heart Disorders
- The Rise in Geriatric Population
- Adoption of Interventional Radiology Procedures
- Delay of Manufacturing Activities
- Fluctuating Price of Raw Materials
- Advancement of Technology
- Increasing New Product Development and Approvals by The Leading Innovative Players
- Increasing Number of Players in The Market Creating Competition
In 2017 Bayer launched its Medrad MRXperion, a magnetic resonance injection system after receiving approval from U. S. Food and Drug Administration (FDA).
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Providers of Power Injection Infusion, Venture Capitalists and Private Equity Firms and End-Use Industry
Frequently Asked Questions (FAQ):
1. Which factors would majorly drive the Power Injection Infusion Market?
"Increasing Prevalence of Cardiovascular Heart Disorders
" is seen as one of major growth factors of Power Injection Infusion Market in years to come.
2. Can we have customized study for Power Injection Infusion Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.